American Riviera reports smaller net income, adds hundreds of new depositors
American Riviera Bank, based in Santa Barbara, reported a net income of $3 million for the quarter ending on March 31, representing a decrease of 6% over the same period last year. Earnings per share for the first quarter totaled 52 cents per share, compared with 55 cents per share this time last year, according Read More →
Amgen’s revenue dips in the first quarter, still beats earnings estimates
Thousand Oaks-based Amgen delivered a sound earnings beat in the first quarter of 2023, the company announced after the markets closed on April 27. Amgen, one of the largest biotechnology companies in the world, generated net income worth $2.8 billion in the first quarter or $5.28 earnings per share. This nearly doubled last year’s first-quarter Read More →
Teledyne starts the new year strong with earnings beat
Thousand Oaks-based Teledyne Technologies kicked off the earnings season right here on the Central Coast, delivering an earnings and revenue beat for the first quarter of 2023, the company announced on April 26 before the markets opened. Teledyne, a technology and defense conglomerate, delivered record revenue results in the first quarter, generating $1.38 billion in Read More →
AppFolio extends contract with large property manager
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Meissner building $250M Georgia plant
Camarillo-based life sciences firm Meissner Corporation is planning to build a second, nearly $250 million manufacturing facility in the United States. The facility will be in Athens-Clarke County, Georgia, which has a modest biotech hub. The project, which the company says is expected to create more than 1,700 jobs over the next eight years, was Read More →
Avocado pricing hurts Calavo’s first quarter
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Analyst remains confident in Inogen despite huge selloff
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
